The Second Life of Methylarginines as Cardiovascular Targets.

6-guanidino-2-oxocaproic acid (GOCA) Homoarginine alanine:glyoxylate aminotransferase 2 (AGXT2) asymmetric dimethylarginine (ADMA) asymmetric α-keto-dimethylguanidinovaleric acid (ADGV) beta-aminoisobutyric acid (BAIBA) dimethylarginine dimethylaminohydrolase (DDAH) symmetric dimethylarginine (SDMA) symmetric α-keto-dimethylguanidinovaleric acid (SDGV)

Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
17 Sep 2019
Historique:
received: 14 08 2019
revised: 13 09 2019
accepted: 15 09 2019
entrez: 20 9 2019
pubmed: 20 9 2019
medline: 6 2 2020
Statut: epublish

Résumé

Endogenous methylarginines were proposed as cardiovascular risk factors more than two decades ago, however, so far, this knowledge has not led to the development of novel therapeutic approaches. The initial studies were primarily focused on the endogenous inhibitors of nitric oxide synthases asymmetric dimethylarginine (ADMA) and monomethylarginine (MMA) and the main enzyme regulating their clearance dimethylarginine dimethylaminohydrolase 1 (DDAH1). To date, all the screens for DDAH1 activators performed with the purified recombinant DDAH1 enzyme have not yielded any promising hits, which is probably the main reason why interest towards this research field has started to fade. The relative contribution of the second DDAH isoenzyme DDAH2 towards ADMA and MMA clearance is still a matter of controversy. ADMA, MMA and symmetric dimethylarginine (SDMA) are also metabolized by alanine: glyoxylate aminotransferase 2 (AGXT2), however, in addition to methylarginines, this enzyme also has several cardiovascular protective substrates, so the net effect of possible therapeutic targeting of AGXT2 is currently unclear. Recent studies on regulation and functions of the enzymes metabolizing methylarginines have given a second life to this research direction. Our review discusses the latest discoveries and controversies in the field and proposes novel directions for targeting methylarginines in clinical settings.

Identifiants

pubmed: 31533264
pii: ijms20184592
doi: 10.3390/ijms20184592
pmc: PMC6769906
pii:
doi:

Substances chimiques

Biomarkers 0
symmetric dimethylarginine 49787G1ULV
N,N-dimethylarginine 63CV1GEK3Y
Arginine 94ZLA3W45F
Amidohydrolases EC 3.5.-
dimethylargininase EC 3.5.3.18

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Références

Sci Rep. 2016 Oct 18;6:35277
pubmed: 27752063
Amino Acids. 2006 May;30(3):279-89
pubmed: 16554972
Am J Cardiol. 2001 Nov 15;88(10):1201-3
pubmed: 11703973
J Chromatogr B Analyt Technol Biomed Life Sci. 2015 Jan 15;975:59-64
pubmed: 25438244
Nat Rev Nephrol. 2011 May;7(5):275-85
pubmed: 21445101
Arterioscler Thromb Vasc Biol. 2013 Nov;33(11):2682-8
pubmed: 24008162
J Am Soc Nephrol. 2006 Apr;17(4):1128-34
pubmed: 16481412
J Am Heart Assoc. 2019 Jul 16;8(14):e012486
pubmed: 31304837
Arterioscler Thromb Vasc Biol. 2011 Jul;31(7):1540-6
pubmed: 21493890
J Biol Chem. 2009 Dec 18;284(51):35338-47
pubmed: 19820234
J Biol Chem. 1989 Jun 15;264(17):10205-9
pubmed: 2722865
Atherosclerosis. 2001 Oct;158(2):425-30
pubmed: 11583722
J Am Soc Nephrol. 2005 Aug;16(8):2456-61
pubmed: 15930091
Circulation. 2003 Dec 16;108(24):3042-7
pubmed: 14638548
J Biol Chem. 1988 Dec 15;263(35):19024-33
pubmed: 2461933
Biochem J. 1978 Jan 15;170(1):173-5
pubmed: 564694
Circulation. 1997 Apr 15;95(8):2068-74
pubmed: 9133517
J Clin Invest. 1992 Oct;90(4):1248-53
pubmed: 1401062
Am J Physiol. 1995 Nov;269(5 Pt 2):H1522-7
pubmed: 7503244
J Biol Chem. 1956 Jul;221(1):425-33
pubmed: 13345831
Amino Acids. 2013 Oct;45(4):989-1002
pubmed: 23864433
Vasc Med. 2005 Jul;10 Suppl 1:S1-2
pubmed: 16444862
Circ Res. 2007 Sep 14;101(6):627-35
pubmed: 17673667
Circ Res. 2010 Feb 19;106(3):551-8
pubmed: 20019334
J Biol Chem. 1990 Dec 5;265(34):20938-45
pubmed: 2123486
Curr Opin Nephrol Hypertens. 2012 Jan;21(1):1-6
pubmed: 22048724
Cardiovasc Res. 2007 Jul 15;75(2):417-25
pubmed: 17559823
Circulation. 2004 Jan 20;109(2):172-7
pubmed: 14662708
Atherosclerosis. 1995 Oct;117(2):273-84
pubmed: 8801873
Stroke. 2006 Aug;37(8):2024-9
pubmed: 16809568
Kidney Int. 2014 Mar;85(3):570-8
pubmed: 24107853
Arterioscler Thromb Vasc Biol. 2012 Nov;32(11):2589-97
pubmed: 22995517
Curr Opin Clin Nutr Metab Care. 2015 Jan;18(1):83-8
pubmed: 25474016
Immunity. 2013 Apr 18;38(4):754-68
pubmed: 23477738
Acta Obstet Gynecol Scand. 1998 Sep;77(8):808-13
pubmed: 9776593
Arterioscler Thromb Vasc Biol. 2015 Jun;35(6):1382-92
pubmed: 25857313
Pharmacol Res. 2009 Dec;60(6):494-502
pubmed: 19666120
J Nutr. 2004 Oct;134(10 Suppl):2842S-2847S; discussion 2853S
pubmed: 15465797
J Am Soc Nephrol. 2015 Dec;26(12):3045-59
pubmed: 25855779
J Am Coll Cardiol. 2001 Jul;38(1):111-6
pubmed: 11451259
Circ Res. 2007 Jul 20;101(2):e2-10
pubmed: 17601800
Circ Cardiovasc Genet. 2013 Oct;6(5):505-13
pubmed: 24047826
Atherosclerosis. 2010 Feb;208(2):518-23
pubmed: 19700158
J Biomol Screen. 2012 Jun;17(5):651-61
pubmed: 22460174
Am J Physiol Renal Physiol. 2008 Jan;294(1):F1-9
pubmed: 17928410
Proc Natl Acad Sci U S A. 1991 Dec 1;88(23):10480-4
pubmed: 1720542
Amino Acids. 2016 Feb;48(2):427-36
pubmed: 26403849
Cell Metab. 2014 Jan 7;19(1):96-108
pubmed: 24411942
FEBS Lett. 2001 Apr 6;494(1-2):48-53
pubmed: 11297733
J Clin Invest. 2017 Dec 1;127(12):4394-4402
pubmed: 29083323
Amino Acids. 2015 Sep;47(9):1703-13
pubmed: 25929587
Biomed Pharmacother. 2019 Mar;111:602-612
pubmed: 30611984
Circulation. 1998 Nov 3;98(18):1842-7
pubmed: 9799202
Anal Biochem. 2014 May 1;452:25-30
pubmed: 24560726
J Inherit Metab Dis. 1985;8(2):75-9
pubmed: 3939535
Bioorg Med Chem. 2012 Sep 15;20(18):5550-8
pubmed: 22921743
Hum Mol Genet. 2006 Jun 1;15(11):1921-30
pubmed: 16644864
Clin Chim Acta. 2003 Oct;336(1-2):1-12
pubmed: 14500028
Genomics. 2000 Aug 15;68(1):101-5
pubmed: 10950934
Circulation. 2015 Jun 23;131(25):2217-25
pubmed: 25910799
Bioorg Med Chem Lett. 2007 Jul 15;17(14):3953-6
pubmed: 17543521
Int J Cardiol. 2016 Jan 15;203:640-6
pubmed: 26580348
Nephron. 1999;83(2):184-5
pubmed: 10516509
Nat Med. 2007 Feb;13(2):198-203
pubmed: 17273169
Arch Biochem Biophys. 1987 Feb 1;252(2):526-37
pubmed: 3101600
Arterioscler Thromb Vasc Biol. 2012 Jun;32(6):1343-53
pubmed: 22460557
Sci Rep. 2017 Mar 10;7:44492
pubmed: 28281693
Vasc Med. 2005 Jul;10 Suppl 1:S3-9
pubmed: 16444863
Eur Heart J. 2005 Sep;26(18):1846-51
pubmed: 15860520
J Biol Chem. 1969 Jan 25;244(2):335-40
pubmed: 5773299
PLoS One. 2012;7(10):e48150
pubmed: 23110194
Cardiol Res Pract. 2011;2011:267257
pubmed: 21637718
ACS Comb Sci. 2019 Apr 8;21(4):241-256
pubmed: 30673277
Biochim Biophys Acta. 1993 Feb 13;1156(2):161-6
pubmed: 8427875
Nitric Oxide. 1997 Feb;1(1):65-73
pubmed: 9701046
J Cardiovasc Pharmacol. 1999 Apr;33(4):652-8
pubmed: 10218738
Biochimie. 2010 Dec;92(12):1801-11
pubmed: 20713123
Arterioscler Thromb Vasc Biol. 2008 May;28(5):961-7
pubmed: 18292394
Clin Chem. 2007 Feb;53(2):273-83
pubmed: 17185364
Early Hum Dev. 2014 Apr;90(4):173-6
pubmed: 24503253
Cell Metab. 2013 Jul 2;18(1):130-43
pubmed: 23823483
J Pathol. 2011 Nov;225(3):344-52
pubmed: 21590769
Biochem Biophys Res Commun. 2013 Jan 4;430(1):84-9
pubmed: 23154179
Sci Transl Med. 2011 Jun 15;3(87):87ra53
pubmed: 21677199
Br J Pharmacol. 1990 Nov;101(3):746-52
pubmed: 1706208
Stroke. 2008 Jan;39(1):180-4
pubmed: 18063827
Circulation. 2005 Mar 22;111(11):1431-8
pubmed: 15781754
J Nephrol. 2008 Nov-Dec;21(6):959-61
pubmed: 19034882
Biochem J. 1999 Oct 1;343 Pt 1:209-14
pubmed: 10493931
Arterioscler Thromb Vasc Biol. 2006 Jul;26(7):1488-94
pubmed: 16574895
Arterioscler Thromb Vasc Biol. 2011 Apr;31(4):890-7
pubmed: 21212404
Lancet. 1992 Mar 7;339(8793):572-5
pubmed: 1347093
Lancet. 2001 Dec 22-29;358(9299):2113-7
pubmed: 11784625
Amino Acids. 2018 Oct;50(10):1347-1356
pubmed: 29982953
Gene. 2017 Dec 30;637:145-151
pubmed: 28942034
Am J Pathol. 2010 May;176(5):2559-70
pubmed: 20348244
Arch Biochem Biophys. 1982 Dec;219(2):454-8
pubmed: 7165312
Biochem Biophys Res Commun. 2019 Aug 27;516(3):963-968
pubmed: 31277947
Biochem J. 1994 Jun 1;300 ( Pt 2):483-9
pubmed: 8002954
Cardiovasc Res. 1999 Aug 15;43(3):542-8
pubmed: 10690326

Auteurs

Natalia Jarzebska (N)

Division of Angiology, Department of Internal Medicine III, University Center for Vascular Medicine, Technische Universität Dresden, 01307 Dresden, Germany. natalia.jarzebska@uniklinikum-dresden.de.
Department of Anaesthesiology and Critical Care Medicine, University Hospital Dresden, Technische Universität Dresden, 01307 Dresden, Germany. natalia.jarzebska@uniklinikum-dresden.de.

Arduino A Mangoni (AA)

Department of Clinical Pharmacology, College of Medicine and Public Health, Flinders University and Flinders Medical Centre, Bedford Park 5042, Adelaide, Australia. arduino.mangoni@flinders.edu.au.

Jens Martens-Lobenhoffer (J)

Institute of Clinical Pharmacology, Otto-von-Guericke University, 39120 Magdeburg, Germany. jens.martens-lobenhoffer@med.ovgu.de.

Stefanie M Bode-Böger (SM)

Institute of Clinical Pharmacology, Otto-von-Guericke University, 39120 Magdeburg, Germany. stefanie.bode-boeger@med.ovgu.de.

Roman N Rodionov (RN)

Division of Angiology, Department of Internal Medicine III, University Center for Vascular Medicine, Technische Universität Dresden, 01307 Dresden, Germany. Roman.Rodionov@uniklinikum-dresden.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH